Ligand validation:6GPK

GDD: GUANOSINE-5'-DIPHOSPHATE-ALPHA-D-MANNOSE

GDD is a Ligand Of Interest in 6GPK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6GPK_GDD_C_408	98%	57%	0.064	0.984	0.96	0.69	1	-	0	0	100%	1
6GPK_GDD_B_409	98%	58%	0.067	0.986	0.97	0.67	3	-	0	0	100%	1
6GPK_GDD_A_415	96%	60%	0.072	0.98	0.87	0.67	1	-	0	0	100%	1
6GPK_GDD_D_405	94%	57%	0.07	0.967	0.9	0.75	2	1	0	0	100%	1
6Q94_GDD_B_402	72%	48%	0.155	0.979	0.7	1.28	-	6	0	0	100%	1
8SG0_GDD_A_404	98%	35%	0.062	0.985	0.97	1.59	2	8	3	0	100%	0.57
2C5E_GDD_B_1372	98%	42%	0.069	0.988	1.07	1.17	2	4	1	0	100%	1
2PK3_GDD_B_411	93%	39%	0.079	0.974	1.2	1.18	1	6	0	0	100%	1
2C59_GDD_A_1377	87%	42%	0.108	0.982	0.91	1.35	1	7	1	0	100%	0.5
2WVM_GDD_B_400	82%	20%	0.124	0.979	1.73	1.62	3	8	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.